海外の治験の状況「1」での検索結果
1852件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- A observational study assessing the real world data on inititating treatment of Toujeo after oral antidiabetic drug failure in insulin-naive patients with Type 2 Diabetes Mellitus patients.
- Type 2 diabetes mellitus without complications
- Colombia, Egypt, India, Indonesia, Israel, Jordan, Kazakhstan, Kuwait, Lebanon, Mexico, Peru, Philippines, Qatar, Russian Federation, Saudi Arabia, Singapore, Taiwan, Thailand, Ukraine, United Arab Emirates
- 2018-02-26
Not Recruiting
- HAbIT Part 1: Incidence of new Human leucocyte antigen (HLA) Antibody formation after Transfusion with blood products in patients with end stage kidney disease who are planned for live donor kidney transplant: A prospective study
- Anaemia;kidney disease; Anaemia kidney disease;Blood - Anaemia;Renal and Urogenital - Kidney disease
- Australia
- 2018-02-20
Not Recruiting
- Resistance Training and Compression Garment in the Management of Breast Cancer-Related Lymphedema
- Cancer breast cancer related lymphedema;Cancer;breast cancer related lymphedema
- Egypt
- 2018-02-12
Not recruiting
- A phase 1 study in healthy volunteers to determine the dermatopharmacokinetics of topically applied diclofenac in combination with the novel penetration enhancer Tocopheryl Phosphate Mixture (TPM), compared with Votaren(registered trademark) gel
- Muscular or joint pain relief in healthy volunteers currently experiencing no pain
- Australia
- 2009-06-24
Not recruiting
- TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients
- HIV Infections;Acquired Immunodeficiency Syndrome;HIV Infections;Acquired Immunodeficiency Syndrome;HIV Infections;Acquired Immunodeficiency Syndrome;HIV Infections;Acquired Immunodeficiency Syndrome
- Argentina, France, South Africa, Thailand, United States
- 2009-05-07
Not recruiting
- A Phase 1/2a Study of ABT-263 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Australia, Germany, United Kingdom, United States
- 2007-05-30
Not recruiting
- The aim of the study is to determine if the development of thyroid disease during treatment with Ribavirin and Interferon-alpha for chronic hepatitis C delivers a better chance of achieving a viral cure.
- Thyroid Disease;Chronic hepatitis C;Thyroid disease
- Australia
- 2010-10-05
Not Recruiting
- Clinical research study involving an experimental combination medication, i.e. one pill containing two experimental medications EVG and COBI and two approved medications for the treatment of HIV-1 infection, FTC and TDF, referred as EVG/COBI/FTC/TDF. This is a study that neither the patient or the investigator will know whether the patient is receiving EVG/COBI/FTC/TDF or the comparator drug ritonavir-boosted atazanavir with FTC/TDF. This is a randomized (by chance, like a flip of a coin) study.
- Human Immunodeficiency Virus (HIV-1) Infections MedDRA version: 14.1 Level: LLT Classification code 10020192 Term: HIV-1 System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Mexico, Netherlands, Portugal, Puerto Rico, Spain, Sweden, Switzerland, Thailand, United Kingdom, United States
- 2010-03-26
Not recruiting
- lymphedema and laser therapy in women with breast cancer
- the effect of low level laser therapy (LLLT) on limb volume, shoulder mobility and hand grip strength in patients with breast cancer related lymphedema
- Egypt
- 2010-01-11
Not recruiting
- Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)
- Type 2 Diabetes Mellitus
- Australia, Belgium, Canada, Colombia, Denmark, France, Germany, Guatemala, Hungary, India, Ireland, Israel, Italy, Korea, Republic of, Lithuania, Mexico, New Zealand, Norway, Peru, Poland, Portugal, Puerto Rico, Russian Federation, South Africa, Spain, Turkey, United Kingdom, United States
- 2011-10-27
Not recruiting
- Investigating the role of targeted therapy Sorafenib - the Fms-like tyrosine kinase 3 (FLT3) inhibitor, in combination with intensive chemotherapy, for previously untreated adult patients with Acute Myeloid Leukaemia (AML) with FLT3 mutations. A Phase II randomised placebo-controlled multi-centre study
- Previously untreated adult acute myeloid leukaemia (AML) with FLT3-ITD mutation.
- Australia
- 2011-10-25
Not recruiting
- Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C
- Hepatitis C Virus (HCV)
- Canada, China, Colombia, Czech Republic, Egypt, Hong Kong, Hungary, India, Ireland, Korea, Republic of, Netherlands, Poland, Romania, Russian Federation, Singapore, Spain, Taiwan, Turkey, United Kingdom, United States
- 2011-10-04
Not Recruiting
- Phase IIa, 2:2:1 randomised, double-blind, placebo-controlled, parallel group, multi-centre clinical trial to investigate the safety, efficacy and pharmacokinetics of recombinant human soluble Fc-gamma receptor IIb (SM101) for intravenous application in the treatment of systemic lupus erythematosus (SLE) patients with or without a history of lupus nephritis
- ;M32 - Systemic lupus erythematosus
- Australia, Belgium, Czech Republic, France, Germany, Italy, Netherlands, Poland, Spain, United Kingdom
- 2011-09-02
Not Recruiting
- A clinical study involving people with severe haemophilia A to look at how safe an experimental replacement factor VIII protein (known as rFVIIIFc) is to take and how well it works to prevent and stop bleeds.
- Severe hemophilia A - defined as 1 IU/dL (1%) endogenous FVIII MedDRA version: 14.1 Level: PT Classification code 10056493 Term: Haemophilia A without inhibitors System Organ Class: 10010331 - Congenital, familial and genetic disorders MedDRA version: 14.1 Level: LLT Classification code 10053753 Term: Hemophilia A without inhibitors System Organ Class: 10010331 - Congenital, familial and genetic disorders MedDRA version: 14.1 Level: LLT Classification code 10018937 Term: Haemophilia A System Organ Class: 10010331 - Congenital, familial and genetic disorders MedDRA version: 14.1 Level: LLT Classification code 10060612 Term: Hemophilia A System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, France, Germany, Hong Kong, India, Israel, Italy, Japan, New Zealand, Poland, Portugal, Russian Federation, South Africa, Spain, Sweden, Switzerland, United Kingdom, United States
- 2011-01-14
Not Recruiting
- Effects of Royal Jelly Supplementation on Regulatory T Cells and Lymphocytes Apoptosis in Children with Systemic Lupus Erythematosus
- Systemic Lupus Erythematosus.
- Africa
- 2016-02-05
Not recruiting
- Testing Effective Strategies for Reducing Child Problem Behavior Among Children Diagnosed with Attention Deficit Hyperactivity Disorder (ADHD): An Evaluation of the 1-2-3 Magic Parenting Program
- Childhood ADHD
- Australia
- 2017-03-16
Not recruiting
- Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
- Dementia;Alzheimer's Disease
- Australia, Canada, South Africa, United States
- 2005-02-24
Not recruiting
- A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents
- HIV-1;HIV Infections
- Argentina, Brazil, Canada, France, Romania, South Africa, Spain, United Kingdom, United States
- 2006-07-21
Not recruiting
- Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Retardation: A Longtitudinal Study
- Prenatal Care;Premature Birth
- Australia, Chile, Italy, Korea, Republic of, United States
- 2006-06-19
Not recruiting
- Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
- Accelerated Phase Chronic Myelogenous Leukemia;Blastic Phase Chronic Myelogenous Leukemia;Childhood Acute Lymphoblastic Leukemia in Remission;Childhood Acute Myeloid Leukemia in Remission;Childhood Chronic Myelogenous Leukemia;Childhood Myelodysplastic Syndromes;Chronic Phase Chronic Myelogenous Leukemia;de Novo Myelodysplastic Syndromes;Disseminated Neuroblastoma;Juvenile Myelomonocytic Leukemia;Previously Treated Childhood Rhabdomyosarcoma;Previously Treated Myelodysplastic Syndromes;Pulmonary Complications;Recurrent Childhood Acute Lymphoblastic Leukemia;Recurrent Childhood Acute Myeloid Leukemia;Recurrent Childhood Large Cell Lymphoma;Recurrent Childhood Lymphoblastic Lymphoma;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Small Noncleaved Cell Lymphoma;Recurrent Neuroblastoma;Recurrent Wilms Tumor and Other Childhood Kidney Tumors;Recurrent/Refractory Childhood Hodgkin Lymphoma;Relapsing Chronic Myelogenous Leukemia;Secondary Acute Myeloid Leukemia;Secondary Myelodysplastic Syndromes;Accelerated Phase Chronic Myelogenous Leukemia;Blastic Phase Chronic Myelogenous Leukemia;Childhood Acute Lymphoblastic Leukemia in Remission;Childhood Acute Myeloid Leukemia in Remission;Childhood Chronic Myelogenous Leukemia;Childhood Myelodysplastic Syndromes;Chronic Phase Chronic Myelogenous Leukemia;de Novo Myelodysplastic Syndromes;Disseminated Neuroblastoma;Juvenile Myelomonocytic Leukemia;Previously Treated Childhood Rhabdomyosarcoma;Previously Treated Myelodysplastic Syndromes;Pulmonary Complications;Recurrent Childhood Acute Lymphoblastic Leukemia;Recurrent Childhood Acute Myeloid Leukemia;Recurrent Childhood Large Cell Lymphoma;Recurrent Childhood Lymphoblastic Lymphoma;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Small Noncleaved Cell Lymphoma;Recurrent Neuroblastoma;Recurrent Wilms Tumor and Other Childhood Kidney Tumors;Recurrent/Refractory Childhood Hodgkin Lymphoma;Relapsing Chronic Myelogenous Leukemia;Secondary Acute Myeloid Leukemia;Secondary Myelodysplastic Syndromes;Accelerated Phase Chronic Myelogenous Leukemia;Blastic Phase Chronic Myelogenous Leukemia;Childhood Acute Lymphoblastic Leukemia in Remission;Childhood Acute Myeloid Leukemia in Remission;Childhood Chronic Myelogenous Leukemia;Childhood Myelodysplastic Syndromes;Chronic Phase Chronic Myelogenous Leukemia;de Novo Myelodysplastic Syndromes;Disseminated Neuroblastoma;Juvenile Myelomonocytic Leukemia;Previously Treated Childhood Rhabdomyosarcoma;Previously Treated Myelodysplastic Syndromes;Pulmonary Complications;Recurrent Childhood Acute Lymphoblastic Leukemia;Recurrent Childhood Acute Myeloid Leukemia;Recurrent Childhood Large Cell Lymphoma;Recurrent Childhood Lymphoblastic Lymphoma;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Small Noncleaved Cell Lymphoma;Recurrent Neuroblastoma;Recurrent Wilms Tumor and Other Childhood Kidney Tumors;Recurrent/Refractory Childhood Hodgkin Lymphoma;Relapsing Chronic Myelogenous Leukemia;Secondary Acute Myeloid Leukemia;Secondary Myelodysplastic Syndromes;Accelerated Phase Chronic Myelogenous Leukemia;Blastic Phase Chronic Myelogenous Leukemia;Childhood Acute Lymphoblastic Leukemia in Remission;Childhood Acute Myeloid Leukemia in Remission;Childhood Chronic Myelogenous Leukemia;Childhood Myelodysplastic Syndromes;Chronic Phase Chronic Myelogenous Leukemia;de Novo Myelodysplastic Syndromes;Disseminated Neuroblastoma;Juvenile Myelomonocytic Leukemia;Previously Treated Childhood Rhabdomyosarcoma;Previously Treated Myelodysplastic Syndromes;Pulmonary Complications;Recurrent Childhood Acute Lymphoblastic Leukemia;Recurrent Childhood Acute Myeloid Leukemia;Recurrent Childhood Large Cell Lymphoma;Recurrent Childhood Lymphoblastic Lymphoma;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Small Noncleaved Cell Lymphoma;Recurrent Neuroblastoma;Recurrent Wilms Tumor and Other Childhood Kidney Tumors;Recurrent/Refractory Childhood Hodgkin Lymphoma;Relapsing Chronic Myelogenous Leukemia;Secondary Acute Myeloid Leukemia;Secondary Myelodysplastic Syndromes
- Australia, Canada, United States
- 2006-03-29
